Emvision Medical Devices Ltd - Asset Resilience Ratio
Emvision Medical Devices Ltd (EMV) has an Asset Resilience Ratio of 0.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Emvision Medical Devices Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how Emvision Medical Devices Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Emvision Medical Devices Ltd balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down Emvision Medical Devices Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Emvision Medical Devices Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$14.59K | 0.06% |
| Total Liquid Assets | AU$14.59K | 0.06% |
Asset Resilience Insights
- Limited Liquidity: Emvision Medical Devices Ltd maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Emvision Medical Devices Ltd Industry Peers by Asset Resilience Ratio
Compare Emvision Medical Devices Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Shandong Weigao Orthopaedic Device Co. Ltd. A
SHG:688161 |
Medical Devices | 6.28% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Ningbo David Medical Device Co Ltd
SHE:300314 |
Medical Devices | 5.11% |
|
Beijing Succeeder Technology Inc
SHG:688338 |
Medical Devices | 28.27% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 3.90% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
Annual Asset Resilience Ratio for Emvision Medical Devices Ltd (2022–2025)
The table below shows the annual Asset Resilience Ratio data for Emvision Medical Devices Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 0.47% | AU$73.65K ≈ $52.11K |
AU$15.57 Million ≈ $11.02 Million |
+0.18pp |
| 2024-06-30 | 0.30% | AU$70.94K ≈ $50.20K |
AU$23.97 Million ≈ $16.96 Million |
-2.38pp |
| 2023-06-30 | 2.68% | AU$308.44K ≈ $218.24K |
AU$11.52 Million ≈ $8.15 Million |
+0.62pp |
| 2022-06-30 | 2.06% | AU$175.12K ≈ $123.91K |
AU$8.51 Million ≈ $6.02 Million |
-- |
About Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more